Organon Philippines, a women’s health company, recently unveiled its Her Health Finder, an online tool that aims to empower ...

Incaier, the healthcare arm of Haier Group, has participated in the expo for five consecutive years. This year, more than 50 ...

Despite announcing strong earnings, Organon & Co.'s ( NYSE:OGN ) stock was sluggish. We did some digging and found ...

Organon's OGN short percent of float has risen 28.4% since its last report. The company recently reported that it has 12.53 ...

Organon (OGN) stock on watch as FDA delays a potential label expansion for its VTAMA cream, impacting 2025 EBITDA margin and ...

Organon ( NYSE: OGN) and partner Shanghai Henlius Biotech said the FDA has accepted the Biologics License Application for ...

Organon & Co. ( NYSE:OGN ) shareholders are probably feeling a little disappointed, since its shares fell 3.1% ...

On Tuesday, Organon & Co (OGN) stock saw a decline, ending the day at $16.46 which represents a decrease of $-0.46 or -2.72% from the prior close of $16.92. The stock opened at $16.74 and touched a ...

On a per-share basis, the Jersey City, New Jersey-based company said it had profit of $1.38. Earnings, adjusted for one-time gains and costs, came to 87 cents per share. The results exceeded Wall ...

Henlius and Organon’s pertuzumab biosimilar met phase 3 goals; Meitheal expanded its US biosimilars; Celltrion’s subcutaneous ...

Organon & Co. ( (OGN) ) has released its Q3 earnings. Here is a breakdown of the information Organon & Co. presented to its ...

Analyst Terence Flynn of Morgan Stanley maintained a Hold rating on Organon (OGN – Research Report), reducing the price target to $17.00.